FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cell and Tissue Violations at IVF

[ Price : $8.95]

FDAs Detroit District says IVF Michigan had significant deviations from regulations for human cells, tissues, and cellular and tis...

Growth in Rx Drug Use Easing

[ Price : $8.95]

A news study says Rx drug expenditure by privately insured people, which has been dropping since 1999, has started to increase aga...

Slowdown in Approvals Not Safety Related: Jenkins

[ Price : $8.95]

CDER Office of New Drugs director John Jenkins tells a financial conference that a recent drop in some first cycle approvals is no...

Physicians Say Samples Influence Prescribing

[ Price : $8.95]

Some obstetricians and gynecologists surveyed say they believe free drug samples from company representatives influence their pres...

Histatrol Promotional Fax Misleading

[ Price : $8.95]

CBER warns Alk-Abello over a Histatrol promotional fax that omitted risk information and use directions.

Panel to Vote on Breast Cancer PMA

[ Price : $8.95]

Federal Register Notice: FDAs Immunology Devices Panel will meet 11/16 to vote on a PMA for a laboratory assay for rapid detection...

2nd Generation Anti-psychotics No More Effective

[ Price : $8.95]

British psychiatrists say atypical antipsychotics dont produce a higher quality of life or symptom relief in schizophrenics than d...

Australian Xenical Ad Draws Fire

[ Price : $8.95]

Australian physicians and consumers are complaining about a DTC ad for Roches Xenical appearing on Australian television.

FDA Fast Track for Lymphoma Drug

[ Price : $8.95]

FDA grants "fast track" status to Allos Therapeutics for its antifolate PDX, indicated for treating patients with T-cell lymphoma.

FDA Sends Info on Responses to Clinical Holds to OMB

[ Price : $8.95]

Federal Register Notice: FDA sends a collection of information on a guidance on submitting and reviewing complete responses to cli...